Anticancer Drugs. 2019 Jan;30(1):91-97. doi: 10.1097/CAD.0000000000000685. Bar-Sela G1,2, Tauber D2, Mitnik I1, Sheinman-Yuffe H1, Bishara-Frolova T3, Aharon-Peretz J3,2. Author information Abstract OBJECTIVES: In patients with cancer, the use of medical cannabis has increased significantly during the recent years. There is evidence that cannabis consumption may affect cognitive performance; however, this potential effect has not been […]
Alcohol Clin Exp Res. 2018 Dec 10. doi: 10.1111/acer.13930. [Epub ahead of print] Adejumo AC1,2, Li J3, Akanbi O4, Adejumo KL5, Bukong TN2,3. Author information Abstract BACKGROUND: Alcoholic gastritis, a superficial erosive disease of the stomach, is a common manifestation of risky alcohol use. In contrast, cannabis which is frequently co-used with alcohol suppresses gastric […]
J Bone Miner Res. 2018 Dec 3. doi: 10.1002/jbmr.3637. [Epub ahead of print] Zhu M1, Yu B2, Bai J2, Wang X1, Guo X2, Liu Y2, Lin J2, Hu S1, Zhang W3, Tao Y2, Hu C1, Yang H2, Xu Y2, Geng D2. Author information Abstract Cannabinoid receptor 2 (CB2) has been implicated as an important clinical […]
Semin Neurol. 2018 Dec;38(6):644-653. doi: 10.1055/s-0038-1673679. Epub 2018 Dec 6. Macone A1, Otis JAD1. Author information Abstract Neuropathic pain management is challenging, and typically requires a multifaceted approach. There are several treatment options, both pharmacologic and nonpharmacologic. Of the available pharmacologic agents, those with the strongest supporting evidence include tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and […]
Pain Manag Nurs. 2018 Dec 6. pii: S1524-9042(18)30209-1. doi: 10.1016/j.pmn.2018.09.006. [Epub ahead of print] Shin S1, Mitchell C2, Mannion K2, Smolyn J2, Meghani SH2. Author information Abstract OBJECTIVE: The objective of this paper is to review the available literature regarding the use of cannabis and cannabinoids in adult oncologic pain management. DESIGN AND DATA SOURCES: […]
J Neurochem. 2018 Dec 6. doi: 10.1111/jnc.14639. [Epub ahead of print] Urbi B1,2, Owusu MA3, Hughes I3, Katz M1, Broadley S1,2, Sabet A1,2. Author information Abstract Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder that results from motor neuron damage. Cannabinoids have been proposed as treatments for ALS due to their anti-excitotoxicity, anti-oxidant, and anti-inflammatory […]
Cleve Clin J Med. 2018 Dec;85(12):943-949. doi: 10.3949/ccjm.85a.17115. Modesto-Lowe V1,2,3, Bojka R2, Alvarado C3. Author information Abstract Cannabis may be an effective alternative or adjunctive treatment for peripheral neuropathy, an often debilitating condition for which standard treatments often provide little relief. Most studies show moderately improved pain from inhaled cannabis use, but adverse effects such as […]
Biochem Pharmacol. 2018 Dec 5. pii: S0006-2952(18)30500-8. doi: 10.1016/j.bcp.2018.12.001. [Epub ahead of print] Askari VR1, Shafiee-Nick R2. Author information Abstract Myelin loss subsequent to oligodendrocyte death has been reported in a variety of myelin-associated disorders such as multiple sclerosis (MS). Lipopolysaccharide (LPS) has been shown to elicit cellular responses in the central nervous system (CNS) […]
J Inflamm (Lond). 2018 Dec 4;15:25. doi: 10.1186/s12950-018-0201-z. eCollection 2018. Du Y1,2,3, Ren P1,2,3, Wang Q4, Jiang SK1,3, Zhang M1,3, Li JY1,3, Wang LL1,3, Guan DW1,3. Author information Abstract BACKGROUND: The anti-inflammatory properties of the cannabinoid 2 receptor (CB2R) in injury and inflammatory diseases have been widely substantiated. Specifically, the anti-inflammatory effect of CB2R may […]
Epilepsia. 2018 Dec 4. doi: 10.1111/epi.14608. [Epub ahead of print] Elliott J1,2, DeJean D3, Clifford T1,4, Coyle D1, Potter BK1, Skidmore B5, Alexander C6, Repetski AE6, Shukla V2, McCoy B7,8, Wells GA1,2. Author information Abstract OBJECTIVE: To assess the benefits and harms of cannabis-based products for pediatric epilepsy. METHODS: We identified in this living systematic […]
